Literature DB >> 21221790

Is obesity a risk factor for Crohn's disease?

Michael A Mendall1, A Viran Gunasekera, B Joseph John, Devinder Kumar.   

Abstract

BACKGROUND: Obesity is associated with a proinflammatory state. AIM: To determine whether obesity at diagnosis is a risk factor for Crohn's disease vs. ulcerative colitis and also vs. community controls and whether there is a U-shaped relationship between body mass index at diagnosis and risk of Crohn's disease versus ulcerative colitis.
METHODS: A total of 524 consecutive inflammatory bowel disease patients attending gastroenterology clinics were administered a questionnaire inquiring about weight at diagnosis and height as well as other risk factors for inflammatory bowel disease. An opportunistic control group of 480 community controls aged 50-70 were randomly selected from the registers of four local general practices as part of another study.
RESULTS: Obesity at diagnosis was more common in subjects with Crohn's disease versus ulcerative colitis odds ratio 2.02 (1.18-3.43) p = 0.0096 and also Crohn's disease versus community controls in the 50-70 year age group (odds ratio 3.22 (1.59-6.52) p = 0.001). There was evidence of a 'dose response' with increasing degrees of obesity associated with increased risk. Low BMI at diagnosis was also associated with risk of Crohn's disease versus ulcerative colitis. A U-shaped relationship between BMI and risk of Crohn's was supported by the strong inverse association of BMI at diagnosis (p = 0.0001) and positive association of BMI at diagnosis squared (p = 0.0002) when they were fitted together into the model.
CONCLUSIONS: Obesity may play a role in the pathogenesis of Crohn's disease and it may be that obesity-related enteropathy is a distinct entity or a sub-type of Crohn's disease.

Entities:  

Mesh:

Year:  2011        PMID: 21221790     DOI: 10.1007/s10620-010-1541-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

Review 1.  Environmental influences on inflammatory bowel disease manifestations. Lessons from epidemiology.

Authors:  Antje Timmer
Journal:  Dig Dis       Date:  2003       Impact factor: 2.404

Review 2.  The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease.

Authors:  Konstantinos Karmiris; Ioannis E Koutroubakis; Elias A Kouroumalis
Journal:  Inflamm Bowel Dis       Date:  2005-09       Impact factor: 5.325

Review 3.  Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?

Authors:  Laurent Peyrin-Biroulet; Mathias Chamaillard; Florent Gonzalez; Elodie Beclin; Cecilia Decourcelle; Laurent Antunes; Jérôme Gay; Christel Neut; Jean-Frédéric Colombel; Pierre Desreumaux
Journal:  Gut       Date:  2006-09-06       Impact factor: 23.059

4.  Modeling nonlinear dose-response relationships in epidemiologic studies: statistical approaches and practical challenges.

Authors:  Susanne May; Carol Bigelow
Journal:  Dose Response       Date:  2006-05-22       Impact factor: 2.658

5.  Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.

Authors:  Paola Brun; Ignazio Castagliuolo; Vincenza Di Leo; Andrea Buda; Massimo Pinzani; Giorgio Palù; Diego Martines
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-10-05       Impact factor: 4.052

Review 6.  Systematic review: adipose tissue, obesity and gastrointestinal diseases.

Authors:  B J John; S Irukulla; A M Abulafi; D Kumar; M A Mendall
Journal:  Aliment Pharmacol Ther       Date:  2006-06-01       Impact factor: 8.171

7.  A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha.

Authors:  Takayoshi Suganami; Junko Nishida; Yoshihiro Ogawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-25       Impact factor: 8.311

8.  Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study.

Authors:  Silvia Delgado-Aros; G Richard Locke; Michael Camilleri; Nicholas J Talley; Sara Fett; Alan R Zinsmeister; L Joseph Melton
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

9.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

Authors:  Haiyan Xu; Glenn T Barnes; Qing Yang; Guo Tan; Daseng Yang; Chieh J Chou; Jason Sole; Andrew Nichols; Jeffrey S Ross; Louis A Tartaglia; Hong Chen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

10.  Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes.

Authors:  Iordanes Karagiannides; Efi Kokkotou; Morris Tansky; Tamara Tchkonia; Nino Giorgadze; Michael O'Brien; Susan E Leeman; James L Kirkland; Charalabos Pothoulakis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

View more
  37 in total

1.  Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production.

Authors:  Erica L Scheller; Kurt D Hankenson; Jayne S Reuben; Paul H Krebsbach
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

Review 2.  Gastrointestinal Complications of Obesity.

Authors:  Michael Camilleri; Harmeet Malhi; Andres Acosta
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

3.  Inflammation: an equal-opportunity process.

Authors:  David B Sachar
Journal:  Dig Dis Sci       Date:  2011-03       Impact factor: 3.199

Review 4.  The microbiota in inflammatory bowel disease.

Authors:  Donal Sheehan; Carthage Moran; Fergus Shanahan
Journal:  J Gastroenterol       Date:  2015-03-26       Impact factor: 7.527

5.  Measures of obesity and risk of Crohn's disease and ulcerative colitis.

Authors:  Hamed Khalili; Ashwin N Ananthakrishnan; Gauree G Konijeti; Leslie M Higuchi; Charles S Fuchs; James M Richter; Andrew T Chan
Journal:  Inflamm Bowel Dis       Date:  2015-02       Impact factor: 5.325

Review 6.  Linking vitamin d deficiency to inflammatory bowel disease.

Authors:  Matthew T Palmer; Casey T Weaver
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325

Review 7.  Outcomes of inflammatory bowel disease surgery in obese versus non-obese patients: a meta-analysis.

Authors:  G Hicks; A Abdulaal; A A P Slesser; Y Mohsen
Journal:  Tech Coloproctol       Date:  2019-09-17       Impact factor: 3.781

Review 8.  Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes.

Authors:  Siddharth Singh; Parambir S Dulai; Amir Zarrinpar; Sonia Ramamoorthy; William J Sandborn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-30       Impact factor: 46.802

Review 9.  Gastrointestinal morbidity in obesity.

Authors:  Andres Acosta; Michael Camilleri
Journal:  Ann N Y Acad Sci       Date:  2014-03-06       Impact factor: 5.691

10.  Inflammatory bowel disease in the obese patient.

Authors:  Marylise Boutros; David Maron
Journal:  Clin Colon Rectal Surg       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.